
Vale: Prof Allan Cripps memorial tribute webinar on pneumococcal disease
Simplifying Pneumococcal Vaccination Across the Lifespan. Australia’s new two-vaccine NIP approach and a must know for GPs, nurses and pharmacists.
Date: July 2 2026, Time: 6:30pm to 7:45pm (AEST)
About
Webinar objective:
- Highlight the new NIP schedule on pneumococcal disease drawing attention to the two-vaccine approach; Prevenar 20 for children less than 18 years and Capvaxive for adults 18 years and over.
- Discuss current pneumococcal disease vaccination coverage and opportunities a two-vaccine approach brings to increase vaccination coverage aligned with NIP eligibility criteria.
Learning outcomes:
- Review the evolving epidemiology and burden of pneumococcal disease in Australia and assess the rationale for the transition to a simplified two-vaccine National Immunisation Program (NIP) schedule.
- Interpret current Australian recommendations for pneumococcal vaccination using Prevenar 20 in children and adolescents and Capvaxive in adults aged 18 years and over.
- Apply practical vaccination pathways in clinical practice to identify eligible patients, support catch-up vaccination, and streamline pneumococcal vaccine delivery across primary care, pharmacy and hospital settings.
- Evaluate barriers and challenges contributing to vaccination against pneumococcal disease and implement strategies, existing and new, to improve vaccination uptake.
Presenters
Chair: Prof Peter Richmond


Professor Peter Richmond is a Consultant Paediatric Immunologist and Paediatrician at Perth Children’s Hospital, and is Head of the Immunology Department at the Child and Adolescent Health Service in WA. He also heads the Vaccine Trials Group within the Wesfarmers Centre of Vaccines and Infectious Diseases at the Telethon Kids Institute, and is Head of the Discipline of Paediatrics at the UWA Medical School. His major research interests are in the prevention of meningitis, pneumonia, respiratory infections and otitis media. He has authored over 300 scientific publications in these areas and has worked in vaccine research for over 25 years.
Prof Paul van Buynder


Professor Paul Van Buynder is a Public Health Physician and past Chairman of the Immunisation Coalition. He is a professor in the School of Medicine at Griffith University in Queensland. He has held senior public health positions in a number of Australian states, in two Canadian jurisdictions and at the Centre for Infections in the UK. He has held personal appointments on sub-committees of National Immunisation Technical Advisory Committees in three continents. Paul is a reviewer of over 10 journals and has over 80 referred book chapters and articles.
Dr Leanne Jones


Dr Jones is a General Practitioner at the Windmill Hill Medical Centre, Launceston and a Director of the Immunisation Coalition (IC).
As a GP with more than 35 years’ experience, Dr Jones has an in-depth knowledge of the health issues facing Tasmanians. Dr Jones was a Board Member of the General Practice North where she served for two years as its Chair, and was a Board member of General Practice Tasmania for eight years. She has a special interest in immunisation and sits on various immunisation advisory and reference groups. She was also the Media Advisor and GP Advisor on Immunisation, and was the Tasmanian Medicare Local spokesperson on Immunisation.
Dr Jones graduated with a BMedSc and MBBS from the University of Tasmania.
She is involved with education of General Practitioners with Primary Health Tasmania and undergraduate medical students at the University of Tasmania.
Haven Moushi


Haven is a community pharmacist and proprietor of two pharmacies in Victoria, with over 10 years of experience as an accredited pharmacist immuniser. She is actively involved in the Monash University Intern Training Program (ITP) vaccination program, supporting the development of future pharmacists through practical immunisation training and mentorship, ensuring they are confident and well-prepared to deliver vaccination services.
Haven also has extensive experience delivering off-site vaccination clinics, including within aged care facilities, helping improve access to essential vaccines for vulnerable populations and supporting broader public health initiatives.
As a pharmacy owner, she integrates immunisation services into everyday practice, fostering a culture of prevention and proactive healthcare within her team. She is committed to expanding the role of pharmacists in primary care and advocating for increased accessibility to vaccinations across diverse communities.
Haven continues to contribute to the profession through leadership, practical experience, and a strong dedication to advancing pharmacist-led immunisation services.
Sonja Elia


After choosing to specialise in Immunisation in 2003, Sonja worked at the Royal Children’s Hospital (RCH) Immunisation service for over 20 years and in 2017, became Victoria’s first Nurse Practitioner (NP) in the field of Immunisation. She is currently the Nursing Lead of the Workforce Immunisation Unit at Austin Health. Sonja has received multiple awards including the Dame Elizabeth Murdoch Nursing
Development scholarship and the RCH Chairman’s medal. She is a current member of the Immunisation Coalition, teaching associate with Monash University NP program and holds an honorary position with the Melbourne Medical School at University of Melbourne.
We would like to thank the following company for supporting this event:

